Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial.
Byung Jin KimKwang Soo ChaWook Hyun ChoEung Ju KimSeung-Hyuk ChoiMoo Hyun KimSang-Hyun KimJun-Bean ParkSeong-Mi ParkIl Suk SohnKyu Hyung RyuIn-Ho ChaePublished in: Journal of cardiovascular pharmacology and therapeutics (2023)
CLinicalTrials.gov identifier NCT04120753.